These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2016726)

  • 1. New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
    Van Schepdael A; Busson R; Vanderhaeghe HJ; Claes PJ; Verbist L; Mingeot-Leclercq MP; Brasseur R; Tulkens PM
    J Med Chem; 1991 Apr; 34(4):1483-92. PubMed ID: 2016726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New derivatives of kanamycin B obtained by modifications and substitutions in position 6''. 2. In vitro and computer-aided toxicological evaluation with respect to interactions with phosphatidylinositol.
    Mingeot-Leclercq MP; Van Schepdael A; Brasseur R; Busson R; Vanderhaeghe HJ; Claes PJ; Tulkens PM
    J Med Chem; 1991 Apr; 34(4):1476-82. PubMed ID: 2016725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation.
    Van Schepdael A; Delcourt J; Mulier M; Busson R; Verbist L; Vanderhaeghe HJ; Mingeot-Leclercq MP; Tulkens PM; Claes PJ
    J Med Chem; 1991 Apr; 34(4):1468-75. PubMed ID: 2016724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
    Reynolds AV; Hamilton-Miller JM; Brumfitt W
    Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycodiversification for the optimization of the kanamycin class aminoglycosides.
    Wang J; Li J; Chen HN; Chang H; Tanifum CT; Liu HH; Czyryca PG; Chang CW
    J Med Chem; 2005 Oct; 48(20):6271-85. PubMed ID: 16190754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antibacterial activity of 1-N-(1,3-dihydroxy-2-propyl)kanamycin B (UK-31,214).
    Richardson K; Brammer KW; Jevons S; Plews RM; Wright JR
    J Antibiot (Tokyo); 1979 Oct; 32(10):973-7. PubMed ID: 528375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antibacterial activities of 1-N [(S)-omega-amino-2-hydroxyalkyl] kanamycin A derivatives.
    Richardson K; Jevons S; Moore JW; Ross BC; Wright JR
    J Antibiot (Tokyo); 1977 Oct; 30(10):843-6. PubMed ID: 591447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
    Kumar V; Remers WA
    J Med Chem; 1979 Apr; 22(4):432-6. PubMed ID: 107311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuning the regioselectivity of the Staudinger reaction for the facile synthesis of kanamycin and neomycin class antibiotics with N-1 modification.
    Li J; Chen HN; Chang H; Wang J; Chang CW
    Org Lett; 2005 Jul; 7(14):3061-4. PubMed ID: 15987205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective modification of the 3''-amino group of kanamycin prevents significant loss of activity in resistant bacterial strains.
    Santana AG; Zárate SG; Asensio JL; Revuelta J; Bastida A
    Org Biomol Chem; 2016 Jan; 14(2):516-525. PubMed ID: 26501183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalently linked kanamycin - Ciprofloxacin hybrid antibiotics as a tool to fight bacterial resistance.
    Shavit M; Pokrovskaya V; Belakhov V; Baasov T
    Bioorg Med Chem; 2017 Jun; 25(11):2917-2925. PubMed ID: 28343755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates.
    Price KE; DeFuria MD; Pursiano TA
    J Infect Dis; 1976 Nov; 134 SUPPL():S249-61. PubMed ID: 62814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antimicrobial and toxicological studies of amino acid and peptide derivatives of kanamycin A and netilmicin.
    Kotretsou S; Mingeot-Leclercq MP; Constantinou-Kokotou V; Brasseur R; Georgiadis MP; Tulkens PM
    J Med Chem; 1995 Nov; 38(23):4710-9. PubMed ID: 7473599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
    Herzog IM; Louzoun Zada S; Fridman M
    J Med Chem; 2016 Sep; 59(17):8008-18. PubMed ID: 27509271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships among the kanamycin aminoglycosides: role of ring I hydroxyl and amino groups.
    Salian S; Matt T; Akbergenov R; Harish S; Meyer M; Duscha S; Shcherbakov D; Bernet BB; Vasella A; Westhof E; Böttger EC
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6104-8. PubMed ID: 22948879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycoside antibiotics. 3. Epimino derivatives of neamine, ribostamycin, and kanamycin B.
    Kumar V; Jones GS; Blacksberg I; Remers WA; Misiek M; Pursiano TA
    J Med Chem; 1980 Jan; 23(1):42-9. PubMed ID: 6244410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of amikacin sulfate (Amikin). A new aminoglycoside antibiotic.
    Schiffman DO
    JAMA; 1977 Oct; 238(14):1547-50. PubMed ID: 578232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of amikacin and kanamycins A and B on dimyristoylphosphatidylglycerol bilayers. An infrared spectroscopic investigation.
    Carrier D; Chartrand N; Matar W
    Biochem Pharmacol; 1997 Feb; 53(3):401-8. PubMed ID: 9065744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of glycodiversification: expedient synthesis and antibacterial evaluation of a library of kanamycin B analogues.
    Li J; Wang J; Czyryca PG; Chang H; Orsak TW; Evanson R; Chang CW
    Org Lett; 2004 Apr; 6(9):1381-4. PubMed ID: 15101747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglycoside antibiotics. XII. Effect of N-alkylation in kanamycin antibiotics.
    Nakagawa S; Toda S; Abe Y; Yamashita H; Fujisawa KI; Naito T; Kawaguchi H
    J Antibiot (Tokyo); 1978 Jul; 31(7):675-80. PubMed ID: 690002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.